{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:30:10Z","timestamp":1780489810856,"version":"3.54.1"},"reference-count":55,"publisher":"VM Media Group sp. z o.o","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MH CZ-DRO","award":["00179906"],"award-info":[{"award-number":["00179906"]}]},{"name":"PROGRES","award":["Q40\/06"],"award-info":[{"award-number":["Q40\/06"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology & Radiotherapy"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.rpor.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T16:58:17Z","timestamp":1582649897000},"page":"318-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cardiotoxicity of radiation therapy in esophageal cancer"],"prefix":"10.5603","volume":"25","author":[{"given":"Milan","family":"Vo\u0161mik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4520-2824","authenticated-orcid":false,"given":"Miroslav","family":"Hodek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Buka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"S\u00fdkorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-1344","authenticated-orcid":false,"given":"Jakub","family":"Grepl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Paluska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Paul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sir\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"key":"10.1016\/j.rpor.2020.02.005_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/CEJ.0000000000000249","article-title":"Worldwide incidence, mortality and time trends for cancer of the oesophagus","volume":"26","author":"Gupta","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.rpor.2020.02.005_bib0010","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1038\/s41598-018-19819-8","article-title":"Global Incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries","volume":"8","author":"Wong","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpor.2020.02.005_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.11.008","article-title":"Risk factors for oesophageal cancer","volume":"36\u201337","author":"Xie","year":"2018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0020","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/annonc\/mds181","article-title":"The incidence of esophageal adenocarcinoma continues to rise: Analysis of period and birth cohort effects on recent trends","volume":"23","author":"Thrift","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jso.24592","article-title":"Global trends in esophageal cancer","volume":"115","author":"Malhotra","year":"2017","journal-title":"J Surg Oncol"},{"issue":"suppl 5","key":"10.1016\/j.rpor.2020.02.005_bib0030","doi-asserted-by":"crossref","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","article-title":"Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Lordick","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0035","unstructured":"The National Comprehensive Cancer Network (NCCN). Esophageal and Esophagogastric Junction Cancer. Version 1.2019. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdf [accessed 23 April 2019]."},{"key":"10.1016\/j.rpor.2020.02.005_bib0040","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","article-title":"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group","volume":"281","author":"Cooper","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.rpor.2020.02.005_bib0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/COC.0b013e3181aaca26","article-title":"Cisplatin\/Irinotecan versus carboplatin\/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer","volume":"33","author":"Ruppert","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"F\u00e9d\u00e9ration Francophone de Canc\u00e9rologie Digestive and UNICANCER-GI Group. Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0060","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9610(03)00066-7","article-title":"A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer","volume":"185","author":"Urschel","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.rpor.2020.02.005_bib0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gut.2003.025080","article-title":"Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis","volume":"53","author":"Fiorica","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.rpor.2020.02.005_bib0070","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0075","series-title":"International commission on radiation units and measurements (ICRU). prescribing, recording, and reporting photon beam therapy. ICRU report 50","year":"1993"},{"key":"10.1016\/j.rpor.2020.02.005_bib0080","series-title":"International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photon beam therapy (supplement to ICRU Report 50)","year":"1999"},{"key":"10.1016\/j.rpor.2020.02.005_bib0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7150\/jca.13873","article-title":"What is the appropriate clinical target volume for esophageal squamous cell carcinoma? Debate and consensus based on pathological and clinical outcomes","volume":"7","author":"Han","year":"2016","journal-title":"J Cancer"},{"issue":"Dec (12)","key":"10.1016\/j.rpor.2020.02.005_bib0090","first-page":"2313","article-title":"Precise delineation of clinical target volume for crossing-segments thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases","volume":"7","author":"Dong","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.rpor.2020.02.005_bib0095","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.3748\/wjg.v16.i44.5555","article-title":"Technological advances in radiotherapy for esophageal cancer","volume":"16","author":"Vosmik","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"Jan 5(2)","key":"10.1016\/j.rpor.2020.02.005_bib0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rpor.2014.12.006","article-title":"Is dose escalation achievable for esophageal carcinoma?","volume":"20","author":"Vieillevigne","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.rpor.2020.02.005_bib0105","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpor.2020.02.005_bib0110","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0115","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ijrobp.2017.03.026","article-title":"Late cardiac toxicity after mediastinal radiation therapy for Hodgkin lymphoma: contributions of coronary artery and whole heart dose-volume variables to risk prediction","volume":"98","author":"Hahn","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.02.005_bib0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin Lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/dote.12147","article-title":"Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973\u20132008)","volume":"27","author":"Mathieu","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.rpor.2020.02.005_bib0130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2147\/CLEP.S166078","article-title":"Global time trends in the incidence of esophageal squamous cell carcinoma","volume":"10","author":"Wang","year":"2018","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/dote.12123","article-title":"Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008","volume":"27","author":"Worni","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.rpor.2020.02.005_bib0140","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/COC.0000000000000089","article-title":"Long-term treatment outcomes for locally advanced esophageal cancer: a single-institution experience","volume":"39","author":"Sio","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0145","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00066-014-0711-4","article-title":"Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and\/or 5-FU: more than 20 years\u2019 experience at a single institution","volume":"190","author":"Fakhrian","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0150","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpor.2020.02.005_bib0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fcvm.2017.00066","article-title":"Radiation-induced cardiovascular disease: a clinical perspective","volume":"4","author":"Yusuf","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpor.2020.02.005_bib0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11936-018-0627-x","article-title":"Radiation-induced cardiovascular toxicity: mechanisms, prevention, and treatment","volume":"20","author":"Spetz","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.rpor.2020.02.005_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158916","article-title":"Radiation therapy and cardiac death in long-term survivors of esophageal cancer: an analysis of the surveillance, epidemiology, and end result database","volume":"11","author":"Gharzai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.rpor.2020.02.005_bib0170","first-page":"516","article-title":"Increased risk of death due to heart disease after radiotherapy for esophageal cancer","volume":"6","author":"Frandsen","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.radonc.2014.11.037","article-title":"Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer","volume":"114","author":"Beukema","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00066-016-0956-1","article-title":"Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer","volume":"192","author":"Ogino","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.02.005_bib0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijrobp.2013.07.008","article-title":"Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients","volume":"87","author":"Fukada","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.02.005_bib0195","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1200\/JCO.2003.03.055","article-title":"Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus","volume":"21","author":"Ishikura","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0200","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s00066-017-1127-8","article-title":"Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer","volume":"193","author":"Ogino","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.radonc.2012.04.016","article-title":"Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer","volume":"104","author":"Konski","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0210","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.prro.2013.02.001","article-title":"Women at increased risk for cardiac toxicity following chemoradiation therapy for esophageal carcinoma","volume":"3","author":"Tait","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0215","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ijrobp.2017.02.021","article-title":"A multi-institutional analysis of trimodality therapy for esophageal cancer in elderly patients","volume":"98","author":"Lester","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.02.005_bib0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12885-019-5421-y","article-title":"The heart\u2019s exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study","volume":"19","author":"Hayashi","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.rpor.2020.02.005_bib0225","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.rpor.2018.07.013","article-title":"Intrafraction esophageal motion in patients with clinical T1N0 esophageal cancer","volume":"23","author":"Sekii","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.rpor.2020.02.005_bib0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.meddos.2006.12.003","article-title":"Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution","volume":"32","author":"Chen","year":"2007","journal-title":"Med Dosim"},{"key":"10.1016\/j.rpor.2020.02.005_bib0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3857\/roj.2017.00241","article-title":"Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience","volume":"36","author":"Choi","year":"2018","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.rpor.2020.02.005_bib0240","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4103\/0973-1482.138217","article-title":"Dosimetric comparison between volumetric modulated arc therapy (VMAT) vs intensity modulated radiation therapy (IMRT) for radiotherapy of mid esophageal carcinoma","volume":"10","author":"Kataria","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.rpor.2020.02.005_bib0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1120\/jacmp.v15i3.4641","article-title":"Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?","volume":"15","author":"Wu","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.rpor.2020.02.005_bib0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.adro.2017.03.006","article-title":"Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus","volume":"2","author":"Xu","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13014-018-0966-5","article-title":"Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma","volume":"13","author":"Hirano","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0260","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3390\/cancers6042356","article-title":"Analysis of intensity-modulated radiation therapy (IMRT), proton and 3D conformal radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients","volume":"6","author":"Ling","year":"2014","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.rpor.2020.02.005_bib0265","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.07.034","article-title":"Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy","volume":"125","author":"Shiraishi","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0270","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.adro.2017.06.002","article-title":"Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience","volume":"2","author":"Prayongrat","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.rpor.2020.02.005_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dox036","article-title":"Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer","volume":"30","author":"Venkat","year":"2017","journal-title":"Dis Esophagus"}],"container-title":["Reports of Practical Oncology & Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720300195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720300195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:15:44Z","timestamp":1613657744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136720300195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1507136720300195"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2020.02.005","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity of radiation therapy in esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}